Primary peritoneal carcinoma Trials in Oklahoma City, United States
Conditions / Primary peritoneal carcinoma / Oklahoma City, United States
Primary peritoneal carcinoma has been the subject of sustained clinical investigation across multiple research sites.
24 total trials for this combination
Showing top 10 of 24 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02315469 | Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery | COMPLETED | — |
| NCT01139957 | Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer | COMPLETED | — |
| NCT05527184 | First in Human Study of IMGN151 in Recurrent Gynaecological Cancers | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT02631876 | A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer | COMPLETED | PHASE3 |
| NCT00721162 | Study of Ramucirumab in Ovarian Cancer | COMPLETED | PHASE2 |
| NCT05483933 | Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers | COMPLETED | PHASE1 |
| NCT05274451 | A Study to Investigate LYL797 in Adults With Solid Tumors | TERMINATED | PHASE1 |
| NCT05579366 | Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) | RECRUITING | PHASE1/PHASE2 |
| NCT03602079 | Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene | COMPLETED | PHASE1/PHASE2 |
| NCT04314401 | National Cancer Institute "Cancer Moonshot Biobank" | ACTIVE_NOT_RECRUITING | — |